N-Heterocyclic carbene (NHC)-catalyzed oxidation of unactivated aldimines to amides via imine umpolung under aerobic conditions

J Ramarao, S Yadav, K Satyam, S Suresh - RSC advances, 2022 - pubs.rsc.org
Herein, we disclose an NHC-catalyzed aerobic oxidation of unactivated aldimines for the
synthesis of amides via umpolung of imines proceeding through an aza-Breslow …

An update on betrixaban, the challenging anticoagulant agent for extended venous thromboembolism prophylaxis

Y Daryabari, F Amreek… - Journal of …, 2022 - journals.lww.com
Venous thromboembolism (VTE) is a prevalent yet preventable cause of death, particularly
among hospitalized patients. Studies have shown that the risk of VTE remains high for up to …

Preoperative management of anticoagulation in the surgical patient: Highlights of the latest guidelines

H Elgamal, MM Luedi, JK Ender, M Meineri - Best Practice & Research …, 2020 - Elsevier
Oral anticoagulants (OACs) are a class of medications commonly used in the long-term
management of patients at risk of thrombosis. They include warfarin and direct oral …

Use of direct oral anticoagulants in ICU patients. Part I–Applied pharmacology

A Wahab, R Patnaik, M Gurjar - Anaesthesiology Intensive Therapy, 2021 - termedia.pl
Direct oral anticoagulants (DOACs) have revolutionized the field of anticoagulation in the
last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non …

Antifosfolipidový syndrom a vliv přímých inhibitorů na stanovení lupus antikoagulans a možnosti jejich neutralizace

N Hemplová - 2024 - dk.upce.cz
Tato diplomová práce shrnuje v teoretické části informace o antifosfolipidovém sydnromu,
včetně antifosfolipidových protilátek a jejich možnému patologickému účinku v organismu …

Nuevos anticoagulantes orales: comparación entre el edoxaban y el rivaroxaban en el manejo de la extracción dental. Una revisión sistemática

FV Villanueva - 2023 - titula.universidadeuropea.com
Rivaroxaban y edoxaban son nuevos anticoagulantes orales (NOACs) inhibidores del factor
Xa. En pacientes tratados con estos fármacos, el riesgo de hemorragia es aumentado …

[PDF][PDF] TÜM YÖNLERİ İLE AF VE TEDAVİ YAKLAŞIMLARI

V OKTAY - 2022 - scholar.archive.org
Bu üründe yer alan bilgiler sadece lisanslı tıbbi çalışanlar için kaynak olarak sunulmuştur.
Herhangi bir konuda profesyonel tıbbi danışmanlık veya tıbbi tanı amacıyla …